These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 3046895)

  • 21. Detection of leishmania antigen in kala azar patients using monoclonal antibodies.
    Sinha R; Arora SK; Datta U; Sehgal S
    Microbiol Immunol; 1992; 36(4):391-400. PubMed ID: 1406366
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of amastigote-specific antigens of Leishmania donovani using kala-azar patient sera.
    Gupta N; Goyal N; Bhatia N; Kamboj KK; Rastogi AK
    Indian J Exp Biol; 2001 Jul; 39(7):623-8. PubMed ID: 12019753
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Kala-azar infected serum circulating antigens and their characteristics detected by monoclonal antibody.
    Hu XS; Liu Q; Lin FQ; Yi TL; Wang YJ; Qin Z; Luo P; Wang L
    Chin Med J (Engl); 1988 Jan; 101(1):1-6. PubMed ID: 3142725
    [No Abstract]   [Full Text] [Related]  

  • 24. Epidemiological study of kala-azar by direct agglutination test in two rural communities of eastern Nepal.
    Koirala S; Karki P; Das ML; Parija SC; Karki BM
    Trop Med Int Health; 2004 Apr; 9(4):533-7. PubMed ID: 15078273
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Predicting kala-azar disease manifestations in asymptomatic patients with latent Leishmania donovani infection by detection of antibody against recombinant K39 antigen.
    Singh S; Kumari V; Singh N
    Clin Diagn Lab Immunol; 2002 May; 9(3):568-72. PubMed ID: 11986261
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Noninvasive management of Indian visceral leishmaniasis: clinical application of diagnosis by K39 antigen strip testing at a kala-azar referral unit.
    Sundar S; Sahu M; Mehta H; Gupta A; Kohli U; Rai M; Berman JD; Murray HW
    Clin Infect Dis; 2002 Sep; 35(5):581-6. PubMed ID: 12173133
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of the direct agglutination test based on freeze-dried Leishmania donovani promastigotes for the serodiagnosis of visceral leishmaniasis in Sudanese patients.
    Abdallah KA; Nour BY; Schallig HD; Mergani A; Hamid Z; Elkarim AA; Saeed OK; Mohamadani AA
    Trop Med Int Health; 2004 Oct; 9(10):1127-31. PubMed ID: 15482407
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immune complexes in Indian kala-azar.
    Sehgal S; Aikat BK; Pathania AG
    Bull World Health Organ; 1982; 60(6):945-50. PubMed ID: 6761008
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cutaneous leishmaniasis serodiagnosis by immunoperoxidase assay.
    Halevy D; Sarov B; Sarov I; el-On J
    Isr J Med Sci; 1990 Sep; 26(9):485-90. PubMed ID: 2228558
    [TBL] [Abstract][Full Text] [Related]  

  • 30. B lymphocyte population and immunoglobulins in Indian kala-azar in response to chemotherapy.
    Neogy AB; Nandy A; Dastidar BG; Chowdhury AB
    Acta Trop; 1986 Sep; 43(3):237-44. PubMed ID: 2877550
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Leishmanin skin test in clinical and subclinical kala-azar cases.
    Saran R; Gupta AK; Sharma MC
    J Commun Dis; 1991 Jun; 23(2):135-7. PubMed ID: 1940219
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Antibody pattern in patients with different forms of leishmaniasis (author's transl)].
    Mannweiler E; Lederer I; zum Felde I
    Zentralbl Bakteriol Orig A; 1978 Apr; 240(3):397-402. PubMed ID: 352039
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An endemic focus of visceral leishmaniasis in Meshkin-Shahr, east Azerbaijan province, north-west part of Iran and IFA serological survey of the disease in this area.
    Edrissian GH; Hafizi A; Afshar A; Soleiman-Zadeh G; Movahed-Danesh AM; Garoussi A
    Bull Soc Pathol Exot Filiales; 1988; 81(2):238-48. PubMed ID: 3046770
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Use of rK39 for diagnosis of post kala-azar dermal leishmaniasis in Nepal.
    Das ML; Deb M; Karki BM; Sarif M; Khanal B; Bhattacharya SK; Agrawal S; Koirala S
    Southeast Asian J Trop Med Public Health; 2007 Jul; 38(4):619-25. PubMed ID: 17882997
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Production and characterization of species-specific monoclonal antibodies against Leishmania donovani for immunodiagnosis.
    Jaffe CL; Bennett E; Grimaldi G; McMahon-Pratt D
    J Immunol; 1984 Jul; 133(1):440-7. PubMed ID: 6373932
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Loss of leishmanin skin test antigen sensitivity and potency in a longitudinal study of visceral leishmaniasis in Bangladesh.
    Bern C; Amann J; Haque R; Chowdhury R; Ali M; Kurkjian KM; Vaz L; Wagatsuma Y; Breiman RF; Secor WE; Maguire JH
    Am J Trop Med Hyg; 2006 Oct; 75(4):744-8. PubMed ID: 17038705
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of antibody responses in Indian kala-azar by immunoblot.
    Tiwari V; Jain A; Agarwal M; Mittal B; Pandey HP
    Biochem Mol Biol Int; 1995 Nov; 37(5):959-64. PubMed ID: 8624503
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunodiagnosis of kala-azar.
    Srivastava L
    J Commun Dis; 1985; 17(1 Suppl):83-8. PubMed ID: 3913701
    [No Abstract]   [Full Text] [Related]  

  • 39. [Kala-azar acquired in Croatia].
    Wenzl H; Petritsch W; Decrinis M; Schreiber F; Warnkross H; Pristautz H; Krejs GJ
    Wien Klin Wochenschr; 1992; 104(24):757-60. PubMed ID: 1337639
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differential decline in Leishmania membrane antigen-specific immunoglobulin G (IgG), IgM, IgE, and IgG subclass antibodies in Indian kala-azar patients after chemotherapy.
    Anam K; Afrin F; Banerjee D; Pramanik N; Guha SK; Goswami RP; Saha SK; Ali N
    Infect Immun; 1999 Dec; 67(12):6663-9. PubMed ID: 10569788
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.